---  
layout: startup_page  
title: "RheumaGen"  
id: "rheumagen.com"  
permalink: "/rheumagenrheumagen.com01092025/"  
website: "https://rheumagen.com/"  
funding_round: "Series A"  
funding_amount: "$15M"  
investors: "SPRIM Global Investments, William Taylor Nominees"  
about: "RheumaGen is a cell and gene therapy company developing curative treatments for autoimmune diseases. They focus on editing the human leukocyte antigen (HLA) to prevent the immune system from attacking healthy cells. Their lead program, RG0401, targets treatment-resistant rheumatoid arthritis."  
markets: "Cell and Gene Therapy, Autoimmune Diseases, Biotechnology, Genetics, Life Science"  
hq: "Denver, Colorado, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/rheumagen"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/rheumagen"  
pitchbook: "https://pitchbook.com/profiles/company/483345-37"  

date_display: "09-Jan-2025"  
date: "2025-01-09"

# SEO Optimization  
meta_title: "RheumaGen - Series A Funding ($15M)"  
meta_description: "RheumaGen, RheumaGen is a cell and gene therapy company developing curative treatments for autoimmune diseases. They focus on editing the human leukocyte antigen..."  
meta_keywords: "RheumaGen, Cell and Gene Therapy, Autoimmune Diseases, Biotechnology, Genetics, Life Science, Series A funding"  
canonical_url: "https://startup.projectstartups.com/rheumagenrheumagen.com01092025/"  
---